MYC, Metabolism, and Cancer

Conacci-Sorrell, 2014, An overview of MYC and its interactome, Cold Spring Harb Perspect Med, 4, a014357, 10.1101/cshperspect.a014357

Duesberg, 1977, The RNA of avian acute leukemia virus MC29, Proc Natl Acad Sci U S A, 74, 4320, 10.1073/pnas.74.10.4320

Sheiness, 1978, Identification of nucleotide sequences which may encode the oncogenic capacity of avian retrovirus MC29, J Virol, 28, 600, 10.1128/jvi.28.2.600-610.1978

Bister, 1986, Oncogenes in retroviruses and cells: biochemistry and molecular genetics, Adv Cancer Res, 47, 99, 10.1016/S0065-230X(08)60199-2

Dalla-Favera, 1982, Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells, Proc Natl Acad Sci U S A, 79, 7824, 10.1073/pnas.79.24.7824

Land, 1983, Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes, Nature, 304, 596, 10.1038/304596a0

Zack, 2013, Pan-cancer patterns of somatic copy number alteration, Nat Genet, 45, 1134, 10.1038/ng.2760

Dang, 2012, MYC on the path to cancer, Cell, 149, 22, 10.1016/j.cell.2012.03.003

Morton, 2013, MYC-y mice: from tumour initiation to therapeutic targeting of endogenous MYC, Mol Oncol, 7, 248, 10.1016/j.molonc.2013.02.015

Levens, 2010, You don't muck with MYC, Genes Cancer, 1, 547, 10.1177/1947601910377492

Lal, 2009, miR-24 Inhibits cell proliferation by targeting E2F2, MYC, and other cell-cycle genes via binding to “seedless” 3′UTR microRNA recognition elements, Mol Cell, 35, 610, 10.1016/j.molcel.2009.08.020

Kim, 2009, HuR recruits let-7/RISC to repress c-Myc expression, Genes Dev, 23, 1743, 10.1101/gad.1812509

Sampson, 2007, MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells, Cancer Res, 67, 9762, 10.1158/0008-5472.CAN-07-2462

Wall, 2008, Translational control of c-MYC by rapamycin promotes terminal myeloid differentiation, Blood, 112, 2305, 10.1182/blood-2007-09-111856

Tseng, 2014, PVT1 dependence in cancer with MYC copy-number increase, Nature, 512, 82, 10.1038/nature13311

Farrell, 2014, MYC degradation, Cold Spring Harb Perspect Med, 4, 10.1101/cshperspect.a014365

Sears, 1999, Ras enhances Myc protein stability, Mol Cell, 3, 169, 10.1016/S1097-2765(00)80308-1

Sears, 2000, Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability, Genes Dev, 14, 2501, 10.1101/gad.836800

Magudia, 2012, K-Ras and B-Raf oncogenes inhibit colon epithelial polarity establishment through up-regulation of c-myc, J Cell Biol, 198, 185, 10.1083/jcb.201202108

Lee, 2010, ERK activation drives intestinal tumorigenesis in Apc(min/+) mice, Nat Med, 16, 665, 10.1038/nm.2143

Hung, 2014, A long noncoding RNA connects c-Myc to tumor metabolism, Proc Natl Acad Sci U S A, 111, 18697, 10.1073/pnas.1415669112

Yashiro-Ohtani, 2014, Long-range enhancer activity determines Myc sensitivity to Notch inhibitors in T cell leukemia, Proc Natl Acad Sci U S A, 111, E4946, 10.1073/pnas.1407079111

Herranz, 2014, A NOTCH1-driven MYC enhancer promotes T cell development, transformation and acute lymphoblastic leukemia, Nat Med, 20, 1130, 10.1038/nm.3665

Shi, 2013, Role of SWI/SNF in acute leukemia maintenance and enhancer-mediated Myc regulation, Genes Dev, 27, 2648, 10.1101/gad.232710.113

Xiang, 2014, Human colorectal cancer-specific CCAT1-L lncRNA regulates long-range chromatin interactions at the MYC locus, Cell Res, 24, 513, 10.1038/cr.2014.35

Roussel, 1991, Myc rescue of a mutant CSF-1 receptor impaired in mitogenic signalling, Nature, 353, 361, 10.1038/353361a0

Bowman, 2001, Stat3-mediated Myc expression is required for Src transformation and PDGF-induced mitogenesis, Proc Natl Acad Sci U S A, 98, 7319, 10.1073/pnas.131568898

Barone, 1995, Myc but not Fos rescue of PDGF signalling block caused by kinase-inactive Src, Nature, 378, 509, 10.1038/378509a0

Lau, 1987, Expression of a set of growth-related immediate early genes in BALB/c 3T3 cells: coordinate regulation with c-fos or c-myc, Proc Natl Acad Sci U S A, 84, 1182, 10.1073/pnas.84.5.1182

Palomero, 2006, NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth, Proc Natl Acad Sci U S A, 103, 18261, 10.1073/pnas.0606108103

Weng, 2006, c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia/lymphoma, Genes Dev, 20, 2096, 10.1101/gad.1450406

Chou, 2010, EGFR promotes lung tumorigenesis by activating miR-7 through a Ras/ERK/Myc pathway that targets the Ets2 transcriptional repressor ERF, Cancer Res, 70, 8822, 10.1158/0008-5472.CAN-10-0638

Grisanzio, 2010, Chromosome 8q24-associated cancers and MYC, Genes Cancer, 1, 555, 10.1177/1947601910381380

Ahmadiyeh, 2010, 8q24 prostate, breast, and colon cancer risk loci show tissue-specific long-range interaction with MYC, Proc Natl Acad Sci U S A, 107, 9742, 10.1073/pnas.0910668107

Tuupanen, 2009, The common colorectal cancer predisposition SNP rs6983267 at chromosome 8q24 confers potential to enhanced Wnt signaling, Nat Genet, 41, 885, 10.1038/ng.406

Yochum, 2010, A beta-catenin/TCF-coordinated chromatin loop at MYC integrates 5′ and 3′ Wnt responsive enhancers, Proc Natl Acad Sci U S A, 107, 145, 10.1073/pnas.0912294107

Eischen, 2001, Bax loss impairs Myc-induced apoptosis and circumvents the selection of p53 mutations during Myc-mediated lymphomagenesis, Mol Cell Biol, 21, 7653, 10.1128/MCB.21.22.7653-7662.2001

Zindy, 1998, Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization, Genes Dev, 12, 2424, 10.1101/gad.12.15.2424

Muthalagu, 2014, BIM is the primary mediator of MYC-induced apoptosis in multiple solid tissues, Cell Rep, 8, 1347, 10.1016/j.celrep.2014.07.057

Kaur, 2013, MYC acts via the PTEN tumor suppressor to elicit autoregulation and genome-wide gene repression by activation of the Ezh2 methyltransferase, Cancer Res, 73, 695, 10.1158/0008-5472.CAN-12-2522

Bouchard, 2007, FoxO transcription factors suppress Myc-driven lymphomagenesis via direct activation of Arf, Genes Dev, 21, 2775, 10.1101/gad.453107

Qi, 2004, p19ARF directly and differentially controls the functions of c-Myc independently of p53, Nature, 431, 712, 10.1038/nature02958

Bouchard, 2004, Myc-induced proliferation and transformation require Akt-mediated phosphorylation of FoxO proteins, EMBO J, 23, 2830, 10.1038/sj.emboj.7600279

Schmitz, 2012, Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics, Nature, 490, 116, 10.1038/nature11378

Schmitz, 2014, Oncogenic mechanisms in Burkitt lymphoma, Cold Spring Harb Perspect Med, 4, 10.1101/cshperspect.a014282

Wolf, 2015, Taming of the beast: shaping Myc-dependent amplification, Trends Cell Biol, 25, 241, 10.1016/j.tcb.2014.10.006

Rahl, 2010, c-Myc regulates transcriptional pause release, Cell, 141, 432, 10.1016/j.cell.2010.03.030

Lin, 2012, Transcriptional amplification in tumor cells with elevated c-Myc, Cell, 151, 56, 10.1016/j.cell.2012.08.026

Levens, 2013, Cellular MYCro economics: balancing MYC function with MYC expression, Cold Spring Harb Perspect Med, 3, 10.1101/cshperspect.a014233

Nie, 2012, c-Myc is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells, Cell, 151, 68, 10.1016/j.cell.2012.08.033

Guccione, 2006, Myc-binding-site recognition in the human genome is determined by chromatin context, Nat Cell Biol, 8, 764, 10.1038/ncb1434

Dang, 2014, GENE REGULATION Fine-tuned amplification in cells, Nature, 511, 417, 10.1038/nature13518

Sabo, 2014, Selective transcriptional regulation by Myc in cellular growth control and lymphomagenesis, Nature, 511, 488, 10.1038/nature13537

Walz, 2014, Activation and repression by oncogenic MYC shape tumour-specific gene expression profiles, Nature, 511, 483, 10.1038/nature13473

Thomas, 2015, Interaction with WDR5 promotes target gene recognition and tumorigenesis by MYC, Mol Cell, 58, 440, 10.1016/j.molcel.2015.02.028

Soufi, 2015, Pioneer transcription factors target partial DNA motifs on nucleosomes to initiate reprogramming, Cell, 161, 555, 10.1016/j.cell.2015.03.017

Soufi, 2012, Facilitators and impediments of the pluripotency reprogramming factors' initial engagement with the genome, Cell, 151, 994, 10.1016/j.cell.2012.09.045

Sander, 2008, MYC stimulates EZH2 expression by repression of its negative regulator miR-26a, Blood, 112, 4202, 10.1182/blood-2008-03-147645

Dang, 2014, MYC and the pathway to cancer, 1st ed

van Riggelen, 2010, MYC as a regulator of ribosome biogenesis and protein synthesis, Nat Rev Cancer, 10, 301, 10.1038/nrc2819

Cole, 2009, Specific regulation of mRNA cap methylation by the c-Myc and E2F1 transcription factors, Oncogene, 28, 1169, 10.1038/onc.2008.463

Cowling, 2007, The Myc transactivation domain promotes global phosphorylation of the RNA polymerase II carboxy-terminal domain independently of direct DNA binding, Mol Cell Biol, 27, 2059, 10.1128/MCB.01828-06

Fernandez-Sanchez, 2009, S-adenosyl homocysteine hydrolase is required for Myc-induced mRNA cap methylation, protein synthesis, and cell proliferation, Mol Cell Biol, 29, 6182, 10.1128/MCB.00973-09

Lin, 2008, c-Myc and eIF4F are components of a feedforward loop that links transcription and translation, Cancer Res, 68, 5326, 10.1158/0008-5472.CAN-07-5876

Lin, 2012, Targeting synthetic lethal interactions between Myc and the eIF4F complex impedes tumorigenesis, Cell Rep, 1, 325, 10.1016/j.celrep.2012.02.010

Rosenwald, 1993, Increased expression of eukaryotic translation initiation factors eIF-4E and eIF-2 alpha in response to growth induction by c-myc, Proc Natl Acad Sci U S A, 90, 6175, 10.1073/pnas.90.13.6175

Bywater, 2013, Dysregulation of the basal RNA polymerase transcription apparatus in cancer, Nat Rev Cancer, 13, 299, 10.1038/nrc3496

Wang, 2011, The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation, Immunity, 35, 871, 10.1016/j.immuni.2011.09.021

Rolfe, 1997, Cellular energy utilization and molecular origin of standard metabolic rate in mammals, Physiol Rev, 77, 731, 10.1152/physrev.1997.77.3.731

Gorrini, 2013, Modulation of oxidative stress as an anticancer strategy, Nat Rev Drug Discov, 12, 931, 10.1038/nrd4002

Cairns, 2011, Cancer cell metabolism, Cold Spring Harb Symp Quant Biol, 76, 299, 10.1101/sqb.2011.76.012856

O'sullivan, 2014, Memory CD8(+) T cells use cell-intrinsic lipolysis to support the metabolic programming necessary for development, Immunity, 41, 75, 10.1016/j.immuni.2014.06.005

Lagadinou, 2013, BCL-2 inhibition targets oxidative phosphorylation and selectively eradicates quiescent human leukemia stem cells, Cell Stem Cell, 12, 329, 10.1016/j.stem.2012.12.013

Samudio, 2010, Pharmacologic inhibition of fatty acid oxidation sensitizes human leukemia cells to apoptosis induction, J Clin Invest, 120, 142, 10.1172/JCI38942

Lippman, 2009, Protein kinase A and TORC1 activate genes for ribosomal biogenesis by inactivating repressors encoded by Dot6 and its homolog Tod6, Proc Natl Acad Sci U S A, 106, 19928, 10.1073/pnas.0907027106

Neiman, 2011, Sporulation in the budding yeast Saccharomyces cerevisiae, Genetics, 189, 737, 10.1534/genetics.111.127126

Loomis, 2014, Cell signaling during development of Dictyostelium, Dev Biol, 391, 1, 10.1016/j.ydbio.2014.04.001

Lee, 2005, TOR complex 2 integrates cell movement during chemotaxis and signal relay in Dictyostelium, Mol Biol Cell, 16, 4572, 10.1091/mbc.e05-04-0342

Wang, 2009, Understanding the mechanism of the dormant dauer formation of C. elegans: from genetics to biochemistry, IUBMB Life, 61, 607, 10.1002/iub.211

Jia, 2004, The TOR pathway interacts with the insulin signaling pathway to regulate C. elegans larval development, metabolism and life span, Development, 131, 3897, 10.1242/dev.01255

Brandhorst, 2015, A periodic diet that mimics fasting promotes multi-system regeneration, enhanced cognitive performance, and healthspan, Cell Metab, 22, 86, 10.1016/j.cmet.2015.05.012

Berg, 2002, Biochemistry, 5th ed

Hensley, 2013, Glutamine and cancer: cell biology, physiology, and clinical opportunities, J Clin Invest, 123, 3678, 10.1172/JCI69600

Laplante, 2012, mTOR signaling in growth control and disease, Cell, 149, 274, 10.1016/j.cell.2012.03.017

Donnelly, 2013, The eIF2alpha kinases: their structures and functions, Cell Mol Life Sci, 70, 3493, 10.1007/s00018-012-1252-6

Hardie, 2011, AMP-activated protein kinase: an energy sensor that regulates all aspects of cell function, Genes Dev, 25, 1895, 10.1101/gad.17420111

Teleman, 2008, Nutritional control of protein biosynthetic capacity by insulin via Myc in Drosophila, Cell Metab, 7, 21, 10.1016/j.cmet.2007.11.010

Csibi, 2014, The mTORC1/S6K1 pathway regulates glutamine metabolism through the eIF4B-dependent control of c-Myc translation, Curr Biol, 24, 2274, 10.1016/j.cub.2014.08.007

Peck, 2013, Antagonism between FOXO and MYC Regulates Cellular Powerhouse, Front Oncol, 3, 96, 10.3389/fonc.2013.00096

Delpuech, 2007, Induction of Mxi1-SR alpha by FOXO3a contributes to repression of Myc-dependent gene expression, Mol Cell Biol, 27, 4917, 10.1128/MCB.01789-06

Ferber, 2012, FOXO3a regulates reactive oxygen metabolism by inhibiting mitochondrial gene expression, Cell Death Differ, 19, 968, 10.1038/cdd.2011.179

Jensen, 2011, FoxO3A promotes metabolic adaptation to hypoxia by antagonizing Myc function, EMBO J, 30, 4554, 10.1038/emboj.2011.323

Masui, 2013, mTOR complex 2 controls glycolytic metabolism in glioblastoma through FoxO acetylation and upregulation of c-Myc, Cell Metab, 18, 726, 10.1016/j.cmet.2013.09.013

Kress, 2011, The MK5/PRAK kinase and Myc form a negative feedback loop that is disrupted during colorectal tumorigenesis, Mol Cell, 41, 445, 10.1016/j.molcel.2011.01.023

Cianfanelli, 2015, AMBRA1 links autophagy to cell proliferation and tumorigenesis by promoting c-Myc dephosphorylation and degradation, Nat Cell Biol, 17, 20, 10.1038/ncb3072

Laplante, 2013, Regulation of mTORC1 and its impact on gene expression at a glance, J Cell Sci, 126, 1713

Okuyama, 2010, Downregulation of c-MYC protein levels contributes to cancer cell survival under dual deficiency of oxygen and glucose, Cancer Res, 70, 10213, 10.1158/0008-5472.CAN-10-2720

Zhang, 2007, HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of C-MYC activity, Cancer Cell, 11, 407, 10.1016/j.ccr.2007.04.001

Semenza, 2012, Hypoxia-inducible factors in physiology and medicine, Cell, 148, 399, 10.1016/j.cell.2012.01.021

Ackerman, 2014, Hypoxia, lipids, and cancer: surviving the harsh tumor microenvironment, Trends Cell Biol, 24, 472, 10.1016/j.tcb.2014.06.001

Bertout, 2008, The impact of O2 availability on human cancer, Nat Rev Cancer, 8, 967, 10.1038/nrc2540

Chandel, 2000, Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor-1alpha during hypoxia: a mechanism of O2 sensing, J Biol Chem, 275, 25130, 10.1074/jbc.M001914200

Corn, 2005, Mxi1 is induced by hypoxia in a HIF-1-dependent manner and protects cells from c-Myc-induced apoptosis, Cancer Biol Ther, 4, 1285, 10.4161/cbt.4.11.2299

Gordan, 2007, HIF-2alpha promotes hypoxic cell proliferation by enhancing c-myc transcriptional activity, Cancer Cell, 11, 335, 10.1016/j.ccr.2007.02.006

D'Angelo, 2003, Hypoxia up-regulates prolyl hydroxylase activity: a feedback mechanism that limits HIF-1 responses during reoxygenation, J Biol Chem, 278, 38183, 10.1074/jbc.M302244200

Dang, 2008, The interplay between MYC and HIF in cancer, Nat Rev Cancer, 8, 51, 10.1038/nrc2274

Kim, 2004, Evaluation of myc E-box phylogenetic footprints in glycolytic genes by chromatin immunoprecipitation assays, Mol Cell Biol, 24, 5923, 10.1128/MCB.24.13.5923-5936.2004

Shim, 1997, c-Myc transactivation of LDH-A: implications for tumor metabolism and growth, Proc Natl Acad Sci U S A, 94, 6658, 10.1073/pnas.94.13.6658

Bello-Fernandez, 1993, The ornithine decarboxylase gene is a transcriptional target of c-Myc, Proc Natl Acad Sci U S A, 90, 7804, 10.1073/pnas.90.16.7804

Warburg, 1956, On respiratory impairment in cancer cells, Science, 124, 269, 10.1126/science.124.3215.269

Warburg, 1924, Ueber den Stoffwechsel der Tumoren, Biochemische Zeitschrift, 152, 319

DeBerardinis, 2010, Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer, Oncogene, 29, 313, 10.1038/onc.2009.358

Gao, 2009, c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism, Nature, 458, 762, 10.1038/nature07823

Wise, 2008, Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction, Proc Natl Acad Sci U S A, 105, 18782, 10.1073/pnas.0810199105

Osthus, 2000, Deregulation of glucose transporter 1 and glycolytic gene expression by c-Myc, J Biol Chem, 275, 21797, 10.1074/jbc.C000023200

Fan, 2010, Akt and c-Myc differentially activate cellular metabolic programs and prime cells to bioenergetic inhibition, J Biol Chem, 285, 7324, 10.1074/jbc.M109.035584

Yuneva, 2012, The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type, Cell Metab, 15, 157, 10.1016/j.cmet.2011.12.015

Hu, 2011, 13C-pyruvate imaging reveals alterations in glycolysis that precede c-Myc-induced tumor formation and regression, Cell Metab, 14, 131, 10.1016/j.cmet.2011.04.012

David, 2010, HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer, Nature, 463, 364, 10.1038/nature08697

Morrish, 2009, c-Myc activates multiple metabolic networks to generate substrates for cell-cycle entry, Oncogene, 28, 2485, 10.1038/onc.2009.112

Locasale, 2013, Serine, glycine and one-carbon units: cancer metabolism in full circle, Nat Rev Cancer, 13, 572, 10.1038/nrc3557

Tedeschi, 2013, Contribution of serine, folate and glycine metabolism to the ATP, NADPH and purine requirements of cancer cells, Cell Death Dis, 4, e877, 10.1038/cddis.2013.393

Vazquez, 2013, Overexpression of the mitochondrial folate and glycine-serine pathway: a new determinant of methotrexate selectivity in tumors, Cancer Res, 73, 478, 10.1158/0008-5472.CAN-12-3709

Vazquez, 2011, Serine biosynthesis with one carbon catabolism and the glycine cleavage system represents a novel pathway for ATP generation, PLoS One, 6, e25881, 10.1371/journal.pone.0025881

Sun, 2015, cMyc-mediated activation of serine biosynthesis pathway is critical for cancer progression under nutrient deprivation conditions, Cell Res, 25, 429, 10.1038/cr.2015.33

Wonsey, 2002, The c-Myc target gene PRDX3 is required for mitochondrial homeostasis and neoplastic transformation, Proc Natl Acad Sci U S A, 99, 6649, 10.1073/pnas.102523299

DeBerardinis, 2007, Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis, Proc Natl Acad Sci U S A, 104, 19345, 10.1073/pnas.0709747104

Son, 2013, Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway, Nature, 496, 101, 10.1038/nature12040

Ye, 2014, Serine catabolism regulates mitochondrial redox control during hypoxia, Cancer Discov, 4, 1406, 10.1158/2159-8290.CD-14-0250

Nikiforov, 2002, A functional screen for Myc-responsive genes reveals serine hydroxymethyltransferase, a major source of the one-carbon unit for cell metabolism, Mol Cell Biol, 22, 5793, 10.1128/MCB.22.16.5793-5800.2002

Fan, 2014, Quantitative flux analysis reveals folate-dependent NADPH production, Nature, 510, 298, 10.1038/nature13236

Doherty, 2014, Blocking lactate export by inhibiting the Myc target MCT1 Disables glycolysis and glutathione synthesis, Cancer Res, 74, 908, 10.1158/0008-5472.CAN-13-2034

Brahimi-Horn, 2011, Hypoxia and energetic tumour metabolism, Curr Opin Genet Dev, 21, 67, 10.1016/j.gde.2010.10.006

Kung, 2011, Glutamine synthetase is a genetic determinant of cell type-specific glutamine independence in breast epithelia, PLoS Genet, 7, e1002229, 10.1371/journal.pgen.1002229

Polletta, 2015, SIRT5 regulation of ammonia-induced autophagy and mitophagy, Autophagy, 11, 253, 10.1080/15548627.2015.1009778

Liu, 2008, Global regulation of nucleotide biosynthetic genes by c-Myc, PLoS One, 3, e2722, 10.1371/journal.pone.0002722

Mannava, 2008, Direct role of nucleotide metabolism in C-MYC-dependent proliferation of melanoma cells, Cell Cycle, 7, 2392, 10.4161/cc.6390

Miltenberger, 1995, An E-box-mediated increase in cad transcription at the G1/S-phase boundary is suppressed by inhibitory c-Myc mutants, Mol Cell Biol, 15, 2527, 10.1128/MCB.15.5.2527

Consortium, 2012, An integrated encyclopedia of DNA elements in the human genome, Nature, 489, 57, 10.1038/nature11247

Zeller, 2006, Global mapping of c-Myc binding sites and target gene networks in human B cells, Proc Natl Acad Sci U S A, 103, 17834, 10.1073/pnas.0604129103

Jones, 1996, An essential E box in the promoter of the gene encoding the mRNA cap-binding protein (eukaryotic initiation factor 4E) is a target for activation by c-myc, Mol Cell Biol, 16, 4754, 10.1128/MCB.16.9.4754

Kim, 2000, Induction of ribosomal genes and hepatocyte hypertrophy by adenovirus-mediated expression of c-Myc in vivo, Proc Natl Acad Sci U S A, 97, 11198, 10.1073/pnas.200372597

Pourdehnad, 2013, Myc and mTOR converge on a common node in protein synthesis control that confers synthetic lethality in Myc-driven cancers, Proc Natl Acad Sci U S A, 110, 11988, 10.1073/pnas.1310230110

Ruggero, 2009, The role of Myc-induced protein synthesis in cancer, Cancer Res, 69, 8839, 10.1158/0008-5472.CAN-09-1970

Stumpf, 2011, The cancerous translation apparatus, Curr Opin Genet Dev, 21, 474, 10.1016/j.gde.2011.03.007

Barna, 2008, Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency, Nature, 456, 971, 10.1038/nature07449

Cunningham, 2014, Protein and nucleotide biosynthesis are coupled by a single rate-limiting enzyme, PRPS2, to drive cancer, Cell, 157, 1088, 10.1016/j.cell.2014.03.052

Priolo, 2014, AKT1 and MYC induce distinctive metabolic fingerprints in human prostate cancer, Cancer Res, 74, 7198, 10.1158/0008-5472.CAN-14-1490

Morrish, 2010, Myc-dependent mitochondrial generation of acetyl-CoA contributes to fatty acid biosynthesis and histone acetylation during cell cycle entry, J Biol Chem, 285, 36267, 10.1074/jbc.M110.141606

Edmunds, 2014, c-Myc programs fatty acid metabolism and dictates acetyl-CoA abundance and fate, J Biol Chem, 289, 25382, 10.1074/jbc.M114.580662

Zirath, 2013, MYC inhibition induces metabolic changes leading to accumulation of lipid droplets in tumor cells, Proc Natl Acad Sci U S A, 110, 10258, 10.1073/pnas.1222404110

Iritani, 2002, Modulation of T-lymphocyte development, growth and cell size by the Myc antagonist and transcriptional repressor Mad1, EMBO J, 21, 4820, 10.1093/emboj/cdf492

Gomez-Roman, 2003, Direct activation of RNA polymerase III transcription by c-Myc, Nature, 421, 290, 10.1038/nature01327

Grandori, 2005, c-Myc binds to human ribosomal DNA and stimulates transcription of rRNA genes by RNA polymerase I, Nat Cell Biol, 7, 311, 10.1038/ncb1224

Guo, 2000, Identification of c-myc responsive genes using rat cDNA microarray, Cancer Res, 60, 5922

Johnston, 2014, Socializing with MYC: cell competition in development and as a model for premalignant cancer, Cold Spring Harb Perspect Med, 4, a014274, 10.1101/cshperspect.a014274

de la Cova, 2006, Myc in model organisms: a view from the flyroom, Semin Cancer Biol, 16, 303, 10.1016/j.semcancer.2006.07.010

Johnston, 1999, Drosophila myc regulates cellular growth during development, Cell, 98, 779, 10.1016/S0092-8674(00)81512-3

Lambertsson, 1998, The minute genes in Drosophila and their molecular functions, Adv Genet, 38, 69, 10.1016/S0065-2660(08)60142-X

Brown, 2008, Evolution of the holozoan ribosome biogenesis regulon, BMC Genomics, 9, 442, 10.1186/1471-2164-9-442

Schuhmacher, 1999, Control of cell growth by c-Myc in the absence of cell division, Curr Biol, 9, 1255, 10.1016/S0960-9822(99)80507-7

Schlosser, 2003, A role for c-Myc in the regulation of ribosomal RNA processing, Nucleic Acids Res, 31, 6148, 10.1093/nar/gkg794

Ji, 2011, Cell-type independent MYC target genes reveal a primordial signature involved in biomass accumulation, PLoS One, 6, e26057, 10.1371/journal.pone.0026057

Koh, 2011, Alterations in nucleolar structure and gene expression programs in prostatic neoplasia are driven by the MYC oncogene, Am J Pathol, 178, 1824, 10.1016/j.ajpath.2010.12.040

Hofmann, 2015, Reduced expression of MYC increases longevity and enhances healthspan, Cell, 160, 477, 10.1016/j.cell.2014.12.016

Neff, 2013, Rapamycin extends murine lifespan but has limited effects on aging, J Clin Invest, 123, 3272, 10.1172/JCI67674

Harrison, 2009, Rapamycin fed late in life extends lifespan in genetically heterogeneous mice, Nature, 460, 392, 10.1038/nature08221

Martin-Montalvo, 2013, Metformin improves healthspan and lifespan in mice, Nat Commun, 4, 2192, 10.1038/ncomms3192

Scarpulla, 2008, Transcriptional paradigms in mammalian mitochondrial biogenesis and function, Physiol Rev, 88, 611, 10.1152/physrev.00025.2007

Wallace, 2012, Mitochondria and cancer, Nat Rev Cancer, 12, 685, 10.1038/nrc3365

O'Donnell, 2006, Activation of transferrin receptor 1 by c-Myc enhances cellular proliferation and tumorigenesis, Mol Cell Biol, 26, 2373, 10.1128/MCB.26.6.2373-2386.2006

Rouault, 2015, Mammalian iron-sulphur proteins: novel insights into biogenesis and function, Nat Rev Mol Cell Biol, 16, 45, 10.1038/nrm3909

Li, 2005, Myc stimulates nuclearly encoded mitochondrial genes and mitochondrial biogenesis, Mol Cell Biol, 25, 6225, 10.1128/MCB.25.14.6225-6234.2005

Morrish, 2014, MYC and mitochondrial biogenesis, Cold Spring Harb Perspect Med, 4, 10.1101/cshperspect.a014225

Kim, 2008, Global identification of Myc target genes reveals its direct role in mitochondrial biogenesis and its E-box usage in vivo, PLoS One, 3, e1798, 10.1371/journal.pone.0001798

Ahuja, 2010, Myc controls transcriptional regulation of cardiac metabolism and mitochondrial biogenesis in response to pathological stress in mice, J Clin Invest, 120, 1494, 10.1172/JCI38331

Sheth, 2014, Inhibition of human mitochondrial peptide deformylase causes apoptosis in c-myc-overexpressing hematopoietic cancers, Cell Death Dis, 5, 10.1038/cddis.2014.112

Carroll, 2015, Deregulated Myc requires MondoA/Mlx for metabolic reprogramming and tumorigenesis, Cancer Cell, 27, 271, 10.1016/j.ccell.2014.11.024

Weinberg, 2015, Targeting mitochondria metabolism for cancer therapy, Nat Chem Biol, 11, 9, 10.1038/nchembio.1712

Graves, 2012, Mitochondrial structure, function and dynamics are temporally controlled by c-Myc, PLoS One, 7, e37699, 10.1371/journal.pone.0037699

Wolf, 2013, Miz1 is required to maintain autophagic flux, Nat Commun, 4, 2535, 10.1038/ncomms3535

Schuhmacher, 2013, Dose-dependent regulation of target gene expression and cell proliferation by c-Myc levels, Transcription, 4, 192, 10.4161/trns.25907

Bretones, 2015, Myc and cell cycle control, Biochim Biophys Acta, 1849, 506, 10.1016/j.bbagrm.2014.03.013

Hermeking, 2000, Identification of CDK4 as a target of c-MYC, Proc Natl Acad Sci U S A, 97, 2229, 10.1073/pnas.050586197

Bouchard, 2001, Regulation of cyclin D2 gene expression by the Myc/Max/Mad network: Myc-dependent TRRAP recruitment and histone acetylation at the cyclin D2 promoter, Genes Dev, 15, 2042, 10.1101/gad.907901

Beier, 2000, Induction of cyclin E-cdk2 kinase activity, E2F-dependent transcription and cell growth by Myc are genetically separable events, EMBO J, 19, 5813, 10.1093/emboj/19.21.5813

Dong, 2014, Division of labour between Myc and G1 cyclins in cell cycle commitment and pace control, Nat Commun, 5, 10.1038/ncomms5750

Zeller, 2003, An integrated database of genes responsive to the Myc oncogenic transcription factor: identification of direct genomic targets, Genome Biol, 4, R69, 10.1186/gb-2003-4-10-r69

Aguda, 2008, MicroRNA regulation of a cancer network: consequences of the feedback loops involving miR-17–92, E2F, and Myc, Proc Natl Acad Sci U S A, 105, 19678, 10.1073/pnas.0811166106

Pickering, 2009, miR-17 and miR-20a temper an E2F1-induced G1 checkpoint to regulate cell cycle progression, Oncogene, 28, 140, 10.1038/onc.2008.372

Dominguez-Sola, 2007, Non-transcriptional control of DNA replication by c-Myc, Nature, 448, 445, 10.1038/nature05953

Moncada, 2012, Fulfilling the metabolic requirements for cell proliferation, Biochem J, 446, 1, 10.1042/BJ20120427

Colombo, 2011, Molecular basis for the differential use of glucose and glutamine in cell proliferation as revealed by synchronized HeLa cells, Proc Natl Acad Sci U S A, 108, 21069, 10.1073/pnas.1117500108

Colombo, 2010, Anaphase-promoting complex/cyclosome-Cdh1 coordinates glycolysis and glutaminolysis with transition to S phase in human T lymphocytes, Proc Natl Acad Sci U S A, 107, 18868, 10.1073/pnas.1012362107

Mathews, 2006, DNA precursor metabolism and genomic stability, FASEB J, 20, 1300, 10.1096/fj.06-5730rev

Miller, 2006, A tribute to Sidney Farber– the father of modern chemotherapy, Br J Haematol, 134, 20, 10.1111/j.1365-2141.2006.06119.x

Murphy, 2013, Isotopically nonstationary 13C flux analysis of Myc-induced metabolic reprogramming in B-cells, Metab Eng, 15, 206, 10.1016/j.ymben.2012.07.008

Cermelli, 2014, Synthetic lethal screens as a means to understand and treat MYC-driven cancers, Cold Spring Harb Perspect Med, 4, 10.1101/cshperspect.a014209

Toyoshima, 2012, Functional genomics identifies therapeutic targets for MYC-driven cancer, Proc Natl Acad Sci U S A, 109, 9545, 10.1073/pnas.1121119109

Patra, 2013, Hexokinase 2 is required for tumor initiation and maintenance and its systemic deletion is therapeutic in mouse models of cancer, Cancer Cell, 24, 399-, 10.1016/j.ccr.2013.08.029

Fantin, 2006, Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance, Cancer Cell, 9, 425, 10.1016/j.ccr.2006.04.023

Seth, 2011, On-target inhibition of tumor fermentative glycolysis as visualized by hyperpolarized pyruvate, Neoplasia, 13, 60, 10.1593/neo.101020

Wang, 2012, LDH-A silencing suppresses breast cancer tumorigenicity through induction of oxidative stress mediated mitochondrial pathway apoptosis, Breast Cancer Res Treat, 131, 791, 10.1007/s10549-011-1466-6

Xie, 2014, Targeting lactate dehydrogenase–a inhibits tumorigenesis and tumor progression in mouse models of lung cancer and impacts tumor-initiating cells, Cell Metab, 19, 795, 10.1016/j.cmet.2014.03.003

Wang, 2014, Cell-state-specific metabolic dependency in hematopoiesis and leukemogenesis, Cell, 158, 1309, 10.1016/j.cell.2014.07.048

Le, 2010, Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression, Proc Natl Acad Sci U S A, 107, 2037, 10.1073/pnas.0914433107

Kolappan, 2015, Structures of lactate dehydrogenase A (LDHA) in apo, ternary and inhibitor-bound forms, Acta Crystallogr D Biol Crystallogr, 71, 185, 10.1107/S1399004714024791

Deiab, 2013, High-throughput screening to identify plant derived human LDH-A inhibitors, European J Med Plants, 3, 603, 10.9734/EJMP/2013/5995

Billiard, 2013, Quinoline 3-sulfonamides inhibit lactate dehydrogenase A and reverse aerobic glycolysis in cancer cells, Cancer Metab, 1, 19, 10.1186/2049-3002-1-19

Kohlmann, 2013, Fragment growing and linking lead to novel nanomolar lactate dehydrogenase inhibitors, J Med Chem, 56, 1023, 10.1021/jm3014844

Granchi, 2011, Discovery of N-hydroxyindole-based inhibitors of human lactate dehydrogenase isoform A (LDH-A) as starvation agents against cancer cells, J Med Chem, 54, 1599, 10.1021/jm101007q

Le, 2012, Glucose-independent glutamine metabolism via TCA cycling for proliferation and survival in B cells, Cell Metab, 15, 110, 10.1016/j.cmet.2011.12.009

Wang, 2010, Targeting mitochondrial glutaminase activity inhibits oncogenic transformation, Cancer Cell, 18, 207, 10.1016/j.ccr.2010.08.009

Xiang, 2015, Targeted inhibition of tumor-specific glutaminase diminishes cell-autonomous tumorigenesis, J Clin Invest, 125, 2293, 10.1172/JCI75836

Gross, 2014, Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer, Mol Cancer Ther, 13, 890, 10.1158/1535-7163.MCT-13-0870

Tan, 2013, Pharmacological inhibition of nicotinamide phosphoribosyltransferase (NAMPT), an enzyme essential for NAD+ biosynthesis, in human cancer cells: metabolic basis and potential clinical implications, J Biol Chem, 288, 3500, 10.1074/jbc.M112.394510

Zhuang, 2008, C-MYC overexpression is required for continuous suppression of oncogene-induced senescence in melanoma cells, Oncogene, 27, 6623, 10.1038/onc.2008.258

Soucek, 2013, Inhibition of Myc family proteins eradicates KRas-driven lung cancer in mice, Genes Dev, 27, 504, 10.1101/gad.205542.112

Ilic, 2011, PI3K-targeted therapy can be evaded by gene amplification along the MYC-eukaryotic translation initiation factor 4E (eIF4E) axis, Proc Natl Acad Sci U S A, 108, E699, 10.1073/pnas.1108237108

Yuan, 2013, Phenformin enhances the therapeutic benefit of BRAF(V600E) inhibition in melanoma, Proc Natl Acad Sci U S A, 110, 18226, 10.1073/pnas.1317577110

Parmenter, 2014, Response of BRAF-mutant melanoma to BRAF inhibition is mediated by a network of transcriptional regulators of glycolysis, Cancer Discov, 4, 423, 10.1158/2159-8290.CD-13-0440

Tanaka, 2015, Compensatory glutamine metabolism promotes glioblastoma resistance to mTOR inhibitor treatment, J Clin Invest, 125, 1591, 10.1172/JCI78239

Li, 2015, Synthetic lethality of combined glutaminase and Hsp90 inhibition in mTORC1-driven tumor cells, Proc Natl Acad Sci U S A, 112, E21